(n = 38) | |||||||
---|---|---|---|---|---|---|---|
Stimulant Relapse Risk Scale (total) | Age | Age when diagnosed with SUD (years) | Treatment time period (months) | Abstinence period (months) | Innate resilience | Acquired resilience | |
Stimulant Relapse Risk Scale (total) | 1.000 | −0.087 | − 0.088 | 0.057 | 0.101 | −0.310** | −0.314** |
Age | − 0.087 | 1.000 | 0.600** | 0.492** | 0.189 | −0.040 | 0.130 |
Age when diagnosed with SUD (years) | −0.088 | 0.600 | 1.000 | −0.027 | −0.149 | 0.110 | 0.123 |
Treatment time period (months) | 0.057 | 0.492** | −0.027 | 1.000 | 0.367** | −0.160 | 0.145 |
Abstinence period (months) | 0.101 | 0.189 | −0.149 | 0.367** | 1.000 | −0.007 | −0.180 |
Innate resilience | −0.310** | −0.040 | 0.110 | −0.160 | −0.007 | 1.000 | 0.585** |
Acquired resilience | −0.314** | 0.130 | 0.123 | 0.145** | −0.180 | 0.585** | 1.000 |